Expert Opinion Archives - Cardio ThinkLab

Prof Yuhui Zhang

Dr Raewyn Fisher

Prof Winnie Chee

A/Prof Roy Rasalam

Ms Wendy Bryant

Dr Ameya Joshi

Dr Muthiah Vaduganathan

Prof Emily Lau

Dr Bee Yong Mong

Dr Michael McGee

Prof Andrew JS Coats

Dr Farina Mohd Salleh

Dr Aekarach Ariyachaipanich

Prof John Amerena

Dr Prin Vathesatogkit

Prof Upendra Kaul

Prof Yao Chenling

Dr Kenji Inoue

Prof Guo Wei

Dr Gan Liangying

Dr Cynthia Papendick

Dr Jiang Wenjuan

Dr Katrin Kemp Gudmundsdottir

Dr Katrin Kemp Gudmundsdottir

Prof Andrew Sindone

Prof Andrew Sindone

Dr Antoni Bayes-Genis

Dr David Sim

Dr Philip J Devereaux

Dr Yasunori Takata

Dr James L Januzzi

Dr Evangelos Giannitsis

Dr Evangelos Giannitsis

Dr Evangelos Giannitsis, Dr Raphael Twerenbold

Dr Winchana Srivilaithon, Dr Pisit Hutayanon, +1 more

Dr Winchana Srivilaithon, Dr Pisit Hutayanon

Dr Suguru Asako, Dr Masayuki Shiozaki, +2 more

Dr James L Januzzi

Dr A Mark Richards

Dr James L Januzzi

Dr Masayuki Shiozaki, Dr Suguru Asako

Dr Masayuki Shiozaki

Dr James L Januzzi

Dr James L Januzzi

Dr A Mark Richards

Dr Christian Mueller

Dr Evangelos Giannitsis

Dr Christian Mueller

Dr Christian Mueller

Dr Christian Mueller

Dr James L Januzzi

Dr Raphael Twerenbold

Dr Raphael Twerenbold

Dr Raphael Twerenbold

Dr A Mark Richards

Dr James L Januzzi, Dr A Mark Richards

Dr A Mark Richards

Innovative Strategies to Optimise Heart Failure GDMT at Prince Wales Hospital’s Heart Failure Clinic

STRONG-HF Recommended in Updated China National Heart Failure Guideline 2023

Optimising Heart Failure GDMT with the Rapid Titration (RaT) Pathway comprising several hospitals in Northland

Reducing Mortality and Readmission with HF Multidisciplinary Model of Care

Culturally Sensitive Diabetes Care

HbA1c discrepancies: How can ambulatory glucose proﬁle (AGP) help?

Menopause and Diabetes

Screening for Occult Heart Failure (HF) in Type 2 Diabetes Mellitus (T2DM) using NT-proBNP

Value of biomarker in HFpEF Diagnosis

Sex-specific Differences in Heart Failure

Management of CVD in Patients with Diabetes

Heart Failure Care Beyond City Limits: Insights from a Cardiologist

Implementation of STRONG-HF protocol in heart failure management: an Australian perspective

When every minute counts: A deep dive into IJN Malaysia’s quest for rapid triage for chest pain patients in the ED

Quantum leap in reducing rehospitalization in HF by 70-80% – How and where?

Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment

Perioperative myocardial injury (PMI) management: Challenges and feasibility of active screening in non-cardiac surgeries

Heart Failure Management in India – Overcoming Present Challenges

Rational use of troponin and optimal management of cardiovascular diseases

The evidence for 0/1-hour algorithm for Asia? DROP-Asian ACS Study

Process Optimization for Emergency hs-TnT Detection

Clinical Application Value of NT-proBNP in Chronic Kidney Diseases Patients with Cardiovascular Diseases

High Sensitivity Troponin vs Conventional Troponin: An Expert View

The rationale for the use of hs-cTn in the optimal management of ACS

STROKESTOP II Study: Precision risk screening for atrial fibrillation in elderly

Atrial Fibrillation in Elderly: Screening tools and role of NT-proBNP

Advantages of early NT-proBNP testing in patients suspected with heart failure

NT-proBNP: Increasing Clinical Confidence in Heart Failure Management

What is the Peptide for Life initiative?

Heart Failure in Asia – Present Challenges and Future Strategies

Perioperative Myocardial Infarction in Non-Cardiac Surgery – Why Measuring Troponin is Important?

Heart Failure Prevention in T2DM – Essence of JCS/JDS joint consensus

CANVAS study: NT-proBNP and CVD risk reduction

What should we take note of when using hs-TnT for CKD patient?

Clinical Relevance of hs-Tn age specific cut-offs

Clinical Relevance of hs-TnT gender specific cut-offs

Recommended Steps to Implement 0h/1h Algorithm in Asia

Benefits of 0h/1h Algorithm in a Thai Institution

Benefits of 0h/1h Algorithm to Patients in Asia

How will NT-proBNP testing evolve in the future?

Is NT-proBNP validated for different population groups?

Reference ranges for NT-proBNP & hs-TnT in Asian populations

Benefits of the 0h/1h algorithm in a Japanese institution

Patient Case Studies Using 0h/1h Algorithm

BNP vs NT-proBNP: An Expert View

Impact of ARNi Therapy on Natriuretic Peptide Use

How to Use NT-proBNP for Prognosis and Monitoring?

What Should Hospitals Consider when Implementing Rapid Algorithm?

TRAPID-AMI sub-study: Use of very low concentration of hs-TnT to rule out AMI using a single blood test

Benefits of hs-Tn 0h/1h Algorithm in ED & Hospital

TRAPID-AMI Study: hs-TnT for Rapid Rule In/ Out of AMI

Benefits of hs-Tn 0h/1h Algorithm to Chest Pain Patients

How NT-proBNP Made a Difference: Dr Januzzi’s Patient Story

Impact of hs-Tn on Further Cardiac Testing in Suspected AMI Patients

Switching from Conventional to High-Sensitivity Troponin

How hs-TnT Made a Difference – Dr Twerenbold’s Story

How NT-proBNP Made a Difference: Dr Richards’ Patient Story

Natriuretic Peptides in the Latest ESC & AHA HF Guidelines

Role of Natriuretic Peptides in Patients with Dypsnea